Clinical features of children with Cunninghamella spp. infection: a case report and literature review.
10.12122/j.issn.1673-4254.2022.05.22
- Author:
Fei Feng WU
1
;
Ji Dong TIAN
1
;
Zhou SHE
1
;
Ying LIU
1
;
Wu Qing WAN
1
;
Chuan WEN
1
Author Information
1. Department of Pediatrics, Second Xiangya Hospital of Central South University, Changsha 410011, China.
- Publication Type:Review
- Keywords:
Cunninghamella spp.;
children;
leukemia;
mucormycosis
- MeSH:
Adolescent;
Amphotericin B/therapeutic use*;
Antifungal Agents/therapeutic use*;
Child;
Cunninghamella;
Female;
Humans;
Male;
Mucormycosis/etiology*
- From:
Journal of Southern Medical University
2022;42(5):780-784
- CountryChina
- Language:Chinese
-
Abstract:
We report a case of mucormycosis induced by Cunninghamella spp. infection in a ten-year-old girl with acute lymphoblastic leukemia, who developed fever and respiratory symptoms after chemotherapy and was diagnosed with invasive fungal disease. Peripheral blood DNA sequences were analyzed using metagenomic next-generation sequencing (mNGS), and by comparison with the Pathogens Metagenomics Database (PMDB), we identified Cunninghamella spp. with sequence number 514 as the pathogen. The patient was treated with amphotericin B combined with posaconazole and showed a favorable response. We searched Pubmed, Embase, CNKI, and Wanfang database for reports of cases of Cunninghamella spp. infection in children and retrieved 22 reported cases (including 12 males) with a median age of 13.5 (3-18) years. In these 22 cases, hematological malignancy was the most common underlying condition (19/22), and most of patients experienced an acute onset and rapid progression with respiratory symptoms (14/20) and fever (16/20) as the most common symptoms. CT imaging often showed unilateral lesions with varying imaging findings, including pulmonary nodules or masses, infiltrative changes, and pleural effusion. Definite diagnoses were established in 18 of the cases, and 4 had probable diagnoses; the lungs and skin were the most frequent organs compromised by the infection. A definite diagnosis of Cunninghamella spp. infection still relied on histopathological examination and fungal culture, but the molecular techniques including PCR and mNGS had shown potentials in the diagnosis. Almost all the cases received antifungal treatment after diagnosis (21/22), and 13 patients also underwent surgeries. Death occurred in 9 (42%) of the cases at a median of 19 (4-54) days after onset of the signs or symptoms. The patients receiving antifungal therapy combined with surgery had a high survival rate (9/13, 69%) than those with antifungal therapy alone (3/8, 37%). Invasive fungal disease is a common complication in immunoco-mpromised patients, but Cunninghamella spp. infection is rare and has a high mortality rate. In cases highly suspected of this disease, active diagnosis and early treatment are critical to improve the survival outcomes of the patients.
